Quantum-Si Incorporated

QSI

Healthcare

$1.04+8.19%vs prev close

$0.69

$3.10

52W RangeNear 52W Low

+0.31 (+42.47%)Past 1M

Price

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

6,626,771

Portfolio Weight

0.05%

in ETF 0.53%

Est. Value

$6M

30D Net

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

None

Buy

Hold

Analyst Targets

avg.

$2.50

vs Current ▲ +140.4% upside

Current$1.04

Low ~ High$1.00 ~ $4.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Canaccord Genuity

Hold

$1.00

-3.85%

$0.91

Maintain

2026-03-05

Canaccord Genuity

Hold

$1.50

+44.23%

$1.27

Maintain

2025-12-22

Canaccord Genuity

Hold

$2.00

+92.31%

$2.34

Maintain

2025-10-27

Canaccord Genuity

Hold

$1.00

-3.85%

$1.15

Maintain

2025-09-09

HC Wainwright & Co.

Buy

N/A

$1.41

Maintain

2025-05-19

1 / 3

Avg Target

$2.50

vs Current ▲ +140.4% upside

None

3 analysts

Buy 2Hold 1

Low $1.00

Current $1.04

High $4.00

Firm	Position	Target	Upside	Close	Action	Date
Canaccord Genuity	Hold	$1.00	-3.85%	$0.91	Maintain	26.03.05
Canaccord Genuity	Hold	$1.50	+44.23%	$1.27	Maintain	25.12.22
Canaccord Genuity	Hold	$2.00	+92.31%	$2.34	Maintain	25.10.27
Canaccord Genuity	Hold	$1.00	-3.85%	$1.15	Maintain	25.09.09
HC Wainwright & Co.	Buy	N/A	N/A	$1.41	Maintain	25.05.19

1 / 3

Price Information

Previous Close$0.96

Open$0.97

Day Range$0.96 - $1.04

52-Week Range$0.69 - $3.10

1-Year Change-19.92%

Trading Volume

Volume7,481,928

Avg Volume (3mo)4,159,940

Valuation

Market Cap225.0M

Book Value$1.02

Shares Outstanding196,431,273

Financials

Revenue (TTM)2.4M

Net Income-101,339,000

EPS$-0.51

EBITDA-92,594,000

Profitability

P/E Ratio-

P/B Ratio1.02

Return on Equity (ROE)-46.52%

Return on Assets (ROA)-24.58%

Profit Margin0.00%

EV/EBITDA-0.53

Beta3.16

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)50.00

Company Overview

Quantum-Si Incorporated is a life sciences company developing a single-molecule detection platform for Next Generation Protein Sequencing (NGPS). Their main products include the Platinum and Platinum Pro NGPS instruments, along with library, barcoding, and sequencing kits, and analysis software. These offerings aim to provide researchers with accessible, high-resolution protein analysis for various applications.

P/B

1.02

Price-to-Book

ROE

-46.5%

Persistent loss

Beta

3.16

Extreme volatility

RSI(14)

50.0

Neutral

AI-generated summary. Not investment advice.